IP Library › Assignment 044815/0135
Patent Assignment
Reel/Frame 044815/0135

Security Interest

Recorded: 2018-02-02 Pages: 11
Assignor
ARMAGEN, INC.
Executed: 2018-01-31
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
133 NORTH FAIRFAX STREET, ALEXANDRIA, VIRGINIA, 22314
Covered Properties (31)
Macromolecular Compositions That Cross the Blood-Brain Barrier and Methods of Use Thereof
Application: 14/192,792 →
Publication: US 2014/0288273
Macromolecular Compositions That Cross the Blood-Brain Barrier and Methods of Use Thereof
Application: 14/594,047 →
Publication: US 2015/0203586
Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the Cns
Application: 15/397,649 →
Publication: US 2017/0114152
Fusion Proteins for Delivery of Gdnf to the Cns
Application: 14/144,460 →
Publication: US 2014/0193409
Compositions and Methods for Blood-Brain Barrier Delivery of Igg-Decoy Receptor Fusion Proteins
Application: 15/357,894 →
Publication: US 2017/0066832
Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the Cns
Application: 14/305,402 →
Publication: US 2015/0004160
Methods and Compositions for Increasing Arylsulfatase a Activity in the Cns
Patent: 9,975,955 →
Application: 14/538,721 →
Publication: US 2015/0064184
Methods and Compositions for Increasing Enzyme Activity in the Cns
Application: 14/281,803 →
Publication: US 2015/0023956
Methods and Compositions for Increasing N-Acetylglucosaminidase Activity in the Cns
Application: 14/994,067 →
Publication: US 2016/0208006
Fusion Proteins for Blood-Brain Barrier Delivery
Patent: 8,142,781 →
Application: 11/245,546 →
Publication: US 2007/0081992
Fusion Proteins for Delivery of Erythropoietin to the Cns
Patent: 8,124,095 →
Application: 12/688,842 →
Publication: US 2010/0261647
Nucleic Acids Encoding and Methods of Producing Fusion Proteins
Patent: 8,053,569 →
Application: 11/245,710 →
Publication: US 2007/0082380
Genetically Encoded Multifunctional Compositions Bidirectionally Transported Between Peripheral Blood and the Cns
Patent: 8,759,297 →
Application: 11/841,541 →
Publication: US 2008/0152645
Methods for Diagnosing and Treating Cns Disorders by Trans-Blood-Brain Barrier Delivery of Protein Compositions
Patent: 8,497,246 →
Application: 11/841,594 →
Publication: US 2008/0171055
Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions
Patent: 7,741,446 →
Application: 11/841,623 →
Publication: US 2008/0170994
Methods for Diagnosing Cns Disorders with Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions
Patent: 8,753,610 →
Application: 12/756,093 →
Publication: US 2010/0290985
Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the Cns
Patent: 8,974,791 →
Application: 12/179,806 →
Publication: US 2009/0053219
Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the Cns
Patent: 9,567,400 →
Application: 14/606,239 →
Publication: US 2015/0299328
Fusion Proteins for Delivery of Gdnf to the Cns
Patent: 8,741,260 →
Application: 12/323,232 →
Publication: US 2009/0156498
Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the Cns
Patent: 8,834,874 →
Application: 12/901,481 →
Publication: US 2011/0110935
Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS
Patent: 8,486,399 →
Application: 13/609,099 →
Publication: US 2013/0142794
Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS
Patent: 8,715,661 →
Application: 13/862,250 →
Publication: US 2013/0287773
Methods and Compositions for Increasing Arylsulfatase a Activity in the Cns
Patent: 8,920,801 →
Application: 14/194,463 →
Publication: US 2014/0294822
Fusion Proteins for Blood-Brain Barrier Delivery
Fusion Proteins for Delivery of Erythropoietin to the Cns
Agents for Blood-Brain Barrier Delivery
Compositions and Methods for Blood-Brain Barrier Delivery of Igg-Decoy Receptor Fusion Proteins
Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the Cns
Methods and Compositions for Increasing Arylsulfatase a Activity in the Cns
Methods and Compositions for Increasing Enzyme Activity in the Cns
Methods and Compositions for Increasing Alpha-Iduronidase Activity in the Cns
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 18, 2005
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 017244/0628 →
Assignment of Assignor's Interest Nov 18, 2005
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 017221/0222 →
Assignment of Assignor's Interest Jan 14, 2008
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 020359/0136 →
Assignment of Assignor's Interest Jan 16, 2008
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 020370/0760 →
Assignment of Assignor's Interest Jan 16, 2008
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 020370/0548 →
Assignment of Assignor's Interest Oct 13, 2008
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 021672/0572 →
Assignment of Assignor's Interest Apr 8, 2010
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 024204/0182 →
Assignment of Assignor's Interest Jul 20, 2010
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 024712/0209 →
Assignment of Assignor's Interest Jan 7, 2014
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 031909/0766 →
Confirmatory License May 21, 2014
From: ARMAGEN TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032971/0193 →
Assignment of Assignor's Interest Jun 24, 2014
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 033168/0019 →
Assignment of Assignor's Interest Jul 1, 2014
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 033222/0953 →
Assignment of Assignor's Interest Sep 26, 2014
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 033826/0582 →
Assignment of Assignor's Interest Nov 17, 2014
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 034184/0872 →
Assignment of Assignor's Interest Mar 31, 2015
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 035346/0096 →
Assignment of Assignor's Interest Jun 5, 2015
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 035842/0374 →
Assignment of Assignor's Interest Mar 17, 2016
From: PARDRIDGE, WILLIAM; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 038019/0248 →
Assignment of Assignor's Interest Nov 30, 2016
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 040471/0557 →
Assignment of Assignor's Interest Feb 7, 2017
From: PARDRIDGE, WILLIAM M.; BOADO, RUBEN J.
To: ARMAGEN TECHNOLOGIES, INC.
Reel/Frame 041651/0659 →
Change of Name Mar 22, 2017
From: ARMAGEN TECHNOLOGIES, INC.
To: ARMAGEN, INC.
Reel/Frame 042067/0068 →
Assignment of Assignor's Interest Nov 18, 2019
From: OXFORD FINANCE LLC
To: JCR PHARMACEUTICALS CO., LTD.
Reel/Frame 051042/0528 →
Release of Security Interest Apr 11, 2020
From: JCR PHARMACEUTICALS CO., LTD.
To: ARMAGEN, INC.
Reel/Frame 052373/0585 →
Change of Name Oct 20, 2022
From: ARMAGEN TECHNOLOGIES, INC.
To: ARMAGEN, INC.
Reel/Frame 061736/0137 →